Palantir's access to identifiable NHS England patient data 'dangerous', MPs say (www.theguardian.com)

MPs have raised serious concerns over NHS England's recent decision to grant Palantir access to identifiable patient data, labeling the move as “dangerous” and exacerbating fears about data privacy. This shift allows Palantir, which has a controversial history with data security, to access non-pseudonymised patient information as part of a £330 million contract aimed at using AI to enhance healthcare efficiencies. Internal NHS briefings revealed worries about public trust, emphasizing that while Palantir is classified as a “data processor” and claims it will only operate following NHS guidelines, the situation raises significant ethical questions about patient consent and data privacy. The implications for the AI and health tech community are profound, as this case highlights the tensions between advancing AI technologies in healthcare and safeguarding sensitive patient information. Critics, including the Patients Association and various MPs, argue that allowing private entities like Palantir access to sensitive datasets could lead to increased commercialization of healthcare data, undermining public trust. As public sentiment turns against such contracts—evidenced by polling indicating widespread distrust—there is mounting pressure on policymakers to ensure that data security and patient confidentiality are prioritized in future AI initiatives within the health sector.